July 22, 2015

Cellular Mechanisms Underlying Complete Hematological Response of Chronic Myeloid Leukemia to BRAF and MEK1/2 Inhibition in a Patient with Concomitant Metastatic Melanoma

Los puntos clave no están disponibles para este artículo en este momento.

These studies suggest that further evaluation of the optimal MAPK targeting approach is warranted to extend therapeutic options in CML.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Andrews et al. (Wed,) studied this question.

Preguntar a la IA

Me gusta

Guardar